Evidence Hub

Therapeutic Efficacy of Unani Medicine in the Management of Warme Ghudda -I-Madhī Sulb (Benign Prostatic Hyperplasia): A Case Report

Adnan Ali, Mohammed Sheeraz, Rizwan Husain

International Journal of AYUSH Case Reports, 2025

Abstract

Benign prostatic hyperplasia (BPH) is a non-malignant condition affecting men, particularly those in their 40s, with prevalence increasing to 90% by the 9th decade. It causes distressing lower urinary tract symptoms (LUTS) that impact quality of life and sexual functioning. BPH is associated with phlegm derangement or cold humour and is influenced by factors such as inheritance, metabolic syndrome, obesity, and low physical activity. The Prostatic Symptom Score (IPSS) is commonly used to assess BPH severity. A 45-year-old male patient, diagnosed with BPH, experienced symptoms like difficulty urinating, increased frequency, weak urine stream, and incomplete bladder emptying. However, treatment with a combination of Unani therapeutic interventions, Sharbat-i-Bazuri Mu‘tadil, Habbe Mubarak, and Ma`jūn Ushba significantly improved his LUTS, increased urinary flow rate, and enhanced his quality of life. This study suggests that such Unani treatments offer a promising alternative for managing LUTS associated with BPH.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free